Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive hiv-infected individuals with CD4 cell counts between 50 and 250/mm3

Autor: LEWI, David S., SULEIMAN, Jamal M., UIP, David E., PEDRO, Rogerio J., SOUZA, Rosa A., SULEIMAN, Grace S., ACCETTURI, Conceição, LEITE, Olavo M., ABREU, William B., KALICHMAN, Artur O., MORAES-FILHO, Joaquim P.P., MOTTI, Eduardo F., PECORARO, Maria Lucia C., MAKURATH, Mark R., NESSLY, Michael L., LEAVITT, Randi Y.

Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 No. 1 (2000); 27-36
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 Núm. 1 (2000); 27-36
Revista do Instituto de Medicina Tropical de São Paulo; v. 42 n. 1 (2000); 27-36
Revista do Instituto de Medicina Tropical de São Paulo
Instituto de Medicina Tropical (IMT)
instacron:IMT
Revista do Instituto de Medicina Tropical de São Paulo, Volume: 42, Issue: 1, Pages: 27-36, Published: FEB 2000

Treatment with indinavir has been shown to result in marked decreases in viral load and increases in CD4 cell counts in HIV-infected individuals. A randomized double-blind study to evaluate the efficacy of indinavir alone (800 mg q8h), zidovidine alo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4961a4ff71acc0adc5ca0f33d59b5e6b
https://www.revistas.usp.br/rimtsp/article/view/30404